Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 6 hours 7 min ago

Immutep Aces Phase IIb in First-Line Head and Neck Cancer, Eyes Regulatory Path Ahead

Sat, 12/07/2024 - 02:00
Immutep Aces Phase IIb in First-Line Head and Neck Cancer, Eyes Regulatory Path Ahead 7/12/2024

Senate Unanimously Passes Bill to Reduce Big Pharma Patent Thickets, Increase Competition

Sat, 12/07/2024 - 02:00
Senate Unanimously Passes Bill to Reduce Big Pharma Patent Thickets, Increase Competition 7/12/2024

AbbVie’s Humira Continues to Lose Market Share as Biosimilars Gain Ground: Report

Sat, 12/07/2024 - 02:00
AbbVie’s Humira Continues to Lose Market Share as Biosimilars Gain Ground: Report 7/12/2024

Akebia Ends Deal With CSL Vifor, Unveils Hefty Price Tag for CKD Anemia Drug Vafseo

Sat, 12/07/2024 - 02:00
Akebia Ends Deal With CSL Vifor, Unveils Hefty Price Tag for CKD Anemia Drug Vafseo 7/12/2024

PBMs and Big Pharma Play Blame Game for Inflated Prescription Drug Prices

Sat, 12/07/2024 - 02:00
PBMs and Big Pharma Play Blame Game for Inflated Prescription Drug Prices 7/12/2024

Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff

Sat, 12/07/2024 - 02:00
Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff 7/12/2024

FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected

Sat, 12/07/2024 - 02:00
FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected 7/12/2024

EMA Finds No Link Between GLP-1 Drugs and Suicidal Thoughts, Self-Harm

Wed, 12/04/2024 - 02:00
EMA Finds No Link Between GLP-1 Drugs and Suicidal Thoughts, Self-Harm 4/12/2024

EC Approves Illumina’s Plan to Divest Cancer Diagnostics Maker Grail

Wed, 12/04/2024 - 02:00
EC Approves Illumina’s Plan to Divest Cancer Diagnostics Maker Grail 4/12/2024

AACR, Cancer Treatment and the Promise of Antibody-Drug Conjugates

Wed, 12/04/2024 - 02:00
AACR, Cancer Treatment and the Promise of Antibody-Drug Conjugates 4/12/2024

Enlivex’s Stock Plummets 50% on Phase II Sepsis Results for Cell Therapy

Wed, 12/04/2024 - 02:00
Enlivex’s Stock Plummets 50% on Phase II Sepsis Results for Cell Therapy 4/12/2024

Lilly Suffers Legal Loss in Tirzepatide Case Against Compounding Pharmacy

Wed, 12/04/2024 - 02:00
Lilly Suffers Legal Loss in Tirzepatide Case Against Compounding Pharmacy 4/12/2024

AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma

Wed, 12/04/2024 - 02:00
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma 4/12/2024

Fujifilm Pumps $1.2B into CDMO Capacity in North Carolina, Eyes 680 New Jobs by 2031

Wed, 12/04/2024 - 02:00
Fujifilm Pumps $1.2B into CDMO Capacity in North Carolina, Eyes 680 New Jobs by 2031 4/12/2024

Vaccines, Next-Gen Approaches Target the Toughest Cancers: AACR

Wed, 12/04/2024 - 02:00
Vaccines, Next-Gen Approaches Target the Toughest Cancers: AACR 4/12/2024

CryoEM: Evolution and Best Practices

Wed, 12/04/2024 - 02:00
CryoEM: Evolution and Best Practices 4/12/2024

Pfizer Moves Forward With Obesity Pill, Plans Dose Optimization Studies This Year

Thu, 11/07/2024 - 02:00
Pfizer Moves Forward With Obesity Pill, Plans Dose Optimization Studies This Year 7/11/2024

Ipsen Inks Potential $1B First-in-Class ADC Deal With Foreseen

Thu, 11/07/2024 - 02:00
Ipsen Inks Potential $1B First-in-Class ADC Deal With Foreseen 7/11/2024

Kazia Offers Secondary OS Data to Build FDA Case for Glioblastoma Drug

Thu, 11/07/2024 - 02:00
Kazia Offers Secondary OS Data to Build FDA Case for Glioblastoma Drug 7/11/2024

FDA Rejects Novo’s Once-Weekly Insulin Injection, Cites Manufacturing Process

Thu, 11/07/2024 - 02:00
FDA Rejects Novo’s Once-Weekly Insulin Injection, Cites Manufacturing Process 7/11/2024